Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jun 10;137(23):3163-3164.
doi: 10.1182/blood.2021011368.

Expect the unexpected

Didier Blaise  1
Affiliations
Comment

Expect the unexpected

Didier Blaise. Blood. .
No abstract available

Keywords: MARROW AND STEM CELL TRANSPLANTATION/organ specific toxicity: infectious; cytomegalovirus; retospective study.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: D.B. has received honoraria from Jazz Pharmaceuticals and expertise fees from Molmed.

Figures

None
Multivariate analyses of the combined impact of CMV serostatus, donor source, and PTCy on OS. See Figure 3B in the article by Goldsmith et al that begins on page 3291.
See this image and copyright information in PMC

Comment on

  • Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis.
    Goldsmith SR, Abid MB, Auletta JJ, Bashey A, Beitinjaneh A, Castillo P, Chemaly RF, Chen M, Ciurea S, Dandoy CE, Díaz MÁ, Fuchs E, Ganguly S, Kanakry CG, Kanakry JA, Kim S, Komanduri KV, Krem MM, Lazarus HM, Liu H, Ljungman P, Masiarz R, Mulroney C, Nathan S, Nishihori T, Page KM, Perales MA, Taplitz R, Romee R, Riches M. Goldsmith SR, et al. Blood. 2021 Jun 10;137(23):3291-3305. doi: 10.1182/blood.2020009362. Blood. 2021. PMID: 33657221 Free PMC article. Clinical Trial.

References

    1. Goldsmith SR, Abid MB, Auletta JJ, et al. Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis. Blood. 2021;137(23):3291-3305. - PMC - PubMed
    1. Crocchiolo R, Castagna L, Furst S, et al. The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide. Bone Marrow Transplant. 2016;51(8):1134-1136. - PubMed
    1. Teira P, Battiwalla M, Ramanathan M, et al. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. Blood. 2016;127(20):2427-2438. - PMC - PubMed
    1. Passweg JR, Baldomero H, Chabannon C, et al; European Society for Blood and Marrow Transplantation (EBMT) . The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus. Bone Marrow Transplant. 2020;55(8):1604-1613. - PMC - PubMed
    1. D’Souza A, Fretham C, Lee SJ, et al. Current use of and trends in hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant. 2020;26(8):e177-e182. - PMC - PubMed